Owensboro, KYNCT07828860Now EnrollingIRB Ready

Hidradenitis Suppurativa (HS) Clinical Trial in Owensboro, KY

Access cutting-edge hidradenitis suppurativa (hs) treatment through this phase 1 clinical trial at a research site in Owensboro. Study-provided care at no cost to qualified participants.

Sponsored by Corvus Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this Owensboro location

Preparing your pre-screening questions…

Expert Care in Owensboro

Access hidradenitis suppurativa (hs) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hidradenitis suppurativa (hs) treatment provided free

Apply for This Owensboro Location

Check if you qualify for this hidradenitis suppurativa (hs) clinical trial in Owensboro, KY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Owensboro

    Convenient for KY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Owensboro site if eligible
  4. 4Begin participation

About This Hidradenitis Suppurativa (HS) Study in Owensboro

Safety and Efficacy of Soquelitinib in Adults with Hidradenitis Suppurativa

Sponsor: Corvus Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Adult male or female, ≥18 years of age at the time of signing the informed consent form (ICF)
A diagnosis of moderate-to-severe HS for at least 1 year prior to the Screening visit from review of medical history and/or participant interview.
A total AN count of ≥5 inflammatory lesions (ie, number of abscesses plus number of inflammatory nodules) including at least 2 palpable inflammatory nodules at both the Screening and Baseline (Day 1) visits.
Draining tunnel count of ≤20 at the Screening or Baseline (Day 1) visit.
HS lesions present in at least 2 distinct anatomic areas (eg, left and right axilla), one of which must be at least Hurley Stage II or Hurley Stage III at both the Screening and Baseline (Day 1) visits.
History of inadequate response, intolerance, or contraindication to a course of systemic antibiotics for treatment of HS or exhibited recurrence after discontinuation of antibiotics through study participant interview and/or review of medical history.
Willing and able to undergo the required skin biopsies. Key

Exclusion Criteria

Currently experiencing, or previous history of, other concomitant skin conditions (eg, psoriasis, cutaneous lupus, previous burns, or extensive tattoos) that would interfere with evaluations of the effect of study intervention on HS.
Other active skin diseases or skin infections (bacterial, fungal, or viral) requiring systemic treatment within 30 days of the Baseline visit (Day 1) or that could interfere with the appropriate assessment of HS lesions.
Known immunodeficiency syndrome, history of an invasive infection (eg, sepsis, severe pneumonia, osteomyelitis), or active non-skin-related infection requiring systemic anti-infective treatment within 30 days of Baseline (Day 1).
History of immunosuppression not related to medication (such as common variable hypogammaglobulinemia), history of clinically significant medical conditions (such as anemia, neutropenia, thrombocytopenia, abnormal renal function, or abnormal liver function), planned surgical procedures, or any other reason which in the opinion of the investigator or sponsor would interfere with the participant's participation in this study, would make the participant an unsuitable candidate to receive study intervention, or would put the participant at risk by participating in the study; or permanently wheelchair-bound or bedridden or very poor functional status which prevents the ability to perform self-care.
Have an unstable or uncontrolled illness, including but not limited to cerebrocardiovascular (eg, unstable angina, unstable arterial hypertension, moderate to severe heart failure \[New York Heart Association Class III/IV\]), respiratory, gastrointestinal, endocrine, hematologic, or neurologic disorders that would potentially affect participant safety within the study or confound efficacy and safety assessments.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Owensboro?

Yes, this clinical trial (NCT07828860) has an active research site in Owensboro, KY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hidradenitis Suppurativa (HS) Treatment Options in Owensboro, KY

If you're searching for hidradenitis suppurativa (hs) treatment options in Owensboro, KY, this clinical trial (NCT07828860) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Owensboro research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced hidradenitis suppurativa (hs) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hidradenitis suppurativa (hs) clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Owensboro, KY

See all alzheimers disease clinical trials recruiting in Owensboro — not just this study.

Browse Alzheimers Disease Trials in Owensboro →

Browse More Trials by Condition

Alzheimers Disease TrialsRheumatoid Arthritis TrialsAtopic Dermatitis TrialsHidradenitis Suppurativa TrialsAll Conditions →

Ready to Join in Owensboro?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Owensboro, KY